{"nctId":"NCT00414167","briefTitle":"Craving, Binge Eating and Obesity","startDateStruct":{"date":"2005-12"},"conditions":["Binge Eating Disorder","Obesity"],"count":61,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: bupropion"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"bupropion","otherNames":["wellbutrin","zyban"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* BMI 25-50\n* Able to travel to clinical site (New Haven, CT) for bi-weekly visits.\n\nExclusion Criteria:\n\n* Predisposition to seizures\n* History of anorexia or bulimia nervosa\n* Current Type I or Type II diabetes mellitus","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Frequency of Binge Eating Episodes","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.2"},{"groupId":"OG001","value":"1.0","spread":"1.5"}]}]}]},{"type":"SECONDARY","title":"Percent BMI Loss","description":"Percent loss in Body Mass Index","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"2.6"},{"groupId":"OG001","value":"0.6","spread":"2.1"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":[]}}}